CJC-1295 No DAC Research: A First-Time Researcher FAQ

CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone, supplied as a lyophilized powder strictly for laboratory research use. For a business buyer adding it to a catalog for the first time, three facts settle most of the confusion: the no-DAC form omits the albumin-binding Drug Affinity Complex that defines the DAC version, which is why the two are listed as separate SKUs; the only meaningful evidence of what sits inside a vial is a batch-specific certificate of analysis you can open and read yourself; and wholesale terms should be published as visible tiers rather than gated behind a quote request. Everything below expands those three points into the questions first-time researchers and first-time stockists actually send in.

Why the DAC and no-DAC versions are catalogued separately

CJC-1295 is a modified fragment of growth hormone-releasing hormone. The variant sold with DAC carries an additional chemical group — the Drug Affinity Complex — that binds reversibly to serum albumin in circulation. The variant sold without it, sometimes catalogued under the name modified GRF (1-29), does not carry that group. That single structural difference is the reason the two compounds behave differently in the literature and the reason they are priced, tested and stocked as distinct items.

Preclinical research generally describes the DAC-bearing form as persisting in circulation substantially longer, while the no-DAC form is characterized by a much shorter window of activity. Studies indicate the no-DAC structure produces a more transient signaling profile, which is why research groups examining pulsatile growth hormone release tend to select it over the long-acting variant. That is a description of what investigators report, not a performance claim, and it is the correct level of specificity for a product page or a sales conversation with a downstream buyer.

The practical consequence for a stocking business is simple: these are not interchangeable SKUs, and a customer who ordered one and received the other has a legitimate complaint. Any supplier whose labeling blurs the distinction — or whose certificate of analysis does not name the exact molecule tested — is creating a fulfillment problem you will end up owning.

What buyers are really asking when they ask about preparation

A large share of first-time inquiries are some version of how much diluent, how many units, or what protocol. Real Peptides does not answer those questions, and no compliant supplier should. These compounds are sold for research use only, they are not approved drugs, and providing preparation, administration or dosing guidance would reframe a laboratory material as something it is not. That boundary is not a customer service gap — it is the line that keeps a wholesale account defensible.

What can be discussed is the concentration framework, which is arithmetic rather than instruction. Concentration is mass divided by solution volume, expressed in milligrams per milliliter. A vial labeled at a given milligram mass, brought into solution at a given volume, yields a calculable mg/mL figure. That relationship is the ceiling of what any supplier should put in writing. Anything past it — volumes to draw, syringe graduations, unit conversions, schedules — is preparation guidance, and a supplier who offers it freely is telling you something about how carefully they read their own compliance obligations.

If you resell, this matters twice over. Your own listings inherit the framing you were given. Sourcing from a supplier whose copy stays disciplined makes it far easier to keep your copy disciplined, because you are not quietly importing claims you cannot support.

Reading a certificate of analysis instead of trusting a badge

The phrase 99% pure appears on nearly every peptide site in the market. On its own it means very little. What gives it meaning is a document tied to the specific lot number printed on the vial you received, produced by an analytical method you can name, and available to you without a purchase, a login, or a fee.

The common failure modes are worth recognizing before you place a first order. Some suppliers publish a single representative COA that is years old and applies to no current batch. Some publish a scanned image with the lab's identifying information removed. Some treat lab documentation as a paid add-on. Some simply say tested and decline to elaborate. None of those are verification.

Here is what the core analytical checks actually answer and what a weak version of each looks like:

When you evaluate any supplier, including this one, open a COA before you open an account. If you cannot find one in under a minute for the exact item you intend to buy, you have learned the most important thing about that vendor.

The compliance questions to take to counsel before you stock

This section is informational and is not legal advice. The honest position is that the regulatory treatment of research-use-only peptides is not uniform, and the specifics turn on your business model, your licensing status and your jurisdiction. What follows is a list of questions to resolve with your own attorney and, where relevant, your state board — not a set of conclusions.

Ask how research-use-only materials are treated where you operate, and whether your entity type may hold or resell them at all. Ask what labeling and record-keeping obligations attach to materials sold for laboratory use. Ask what your advertising may and may not say, since marketing copy is frequently where a compliant inventory position turns into a non-compliant business position. Ask whether your professional licensing, if you hold any, changes the analysis — it often does, in both directions. Ask how chain-of-custody documentation should be retained, and for how long. And ask what your obligations are toward downstream buyers, including what representations you are making simply by listing an item.

The reason to run these questions before your first purchase order rather than after is procedural. Unwinding an inventory position, revising published listings and re-papering customer agreements is far more expensive than a single conversation with counsel at the outset. No supplier — including Real Peptides — can make this determination on your behalf, and any supplier who offers to should be treated with suspicion.

How wholesale terms should work, and what to interrogate

Wholesale pricing in this category is uneven by design. Some programs publish nothing, route every inquiry to a sales call, and quote differently depending on how motivated the buyer sounds. That model is not illegal, but it makes cost modeling impossible and it makes your own pricing unstable.

What to interrogate before committing: whether tier thresholds and the pricing at each tier are published in writing; whether minimums apply per SKU or across an order; whether lab documentation is included or billed separately; who bears the cost of a batch that fails your incoming inspection; what the stated fulfillment window is and whether it is measured from order placement or from payment clearance; whether the catalog is stable enough to plan around, or whether items appear and vanish; and whether cold-chain handling is described anywhere. Margins in this category vary widely with volume, category and how you position the product, so treat any supplier who quotes you a specific expected margin as someone guessing about your business.

Storage belongs in the same conversation, because it is an inventory cost. Lyophilized peptides are generally handled cold and protected from light and moisture, with stability depending on the specific compound and its water content. Confirm the storage conditions stated for each item you intend to hold, and make sure your receiving process can actually meet them from the moment a shipment lands.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built around verification rather than assurance. Compounds are manufactured to 99%+ HPLC purity and every batch passes a seven-panel test before release. The resulting certificates of analysis are publicly verifiable — a prospective partner can pull up lab results for a given item and read them without an account, a purchase or a fee, which is the opposite of the COA-as-paid-add-on practice common elsewhere in the category. The catalog page for CJC-1295 No DAC 10mg is a reasonable place to test that claim yourself before any conversation about terms.

Fulfillment is handled domestically, with a stated 5–7 day delivery window in the United States, which removes the customs variability that makes international sourcing hard to plan inventory around. Wholesale onboarding runs through a three-step application: submit the application with your business details, complete verification, and receive tier pricing. All compounds are supplied for research use only and are not approved drugs, and no dosing, preparation or administration guidance is provided at any point in the relationship.

If you are evaluating CJC-1295 no DAC as a first stocking decision, the meaningful comparison is not a price-per-vial line item. It is whether the supplier's lab documentation is checkable, whether the terms are written down, and whether the compliance posture is one you would be comfortable inheriting when a customer asks where the material came from.

Businesses that can answer those questions to their own satisfaction, and that have already had the licensing conversation with their counsel, are the right fit for the Wholesale Partner Program application at Real Peptides — start by reviewing a published certificate of analysis, then submit the application to move into verification and tier pricing.

Related reading for buyers building out a catalog: the Growth Factor & Tissue Signaling Research collection covers compounds frequently evaluated alongside CJC-1295 no DAC, including Ipamorelin 10mg and Tesamorelin 10mg, while the Popular Peptides collection shows which items move most consistently across wholesale accounts.